Cargando…
Inflammatory Cells in Atherosclerosis
Atherosclerosis is a chronic progressive disease that involves damage to the intima, inflammatory cell recruitment and the accumulation of lipids followed by calcification and plaque rupture. Inflammation is considered a key mediator of many events during the development and progression of the disea...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868126/ https://www.ncbi.nlm.nih.gov/pubmed/35204116 http://dx.doi.org/10.3390/antiox11020233 |
_version_ | 1784656190494474240 |
---|---|
author | Mehu, Marcelle Narasimhulu, Chandrakala Aluganti Singla, Dinender K. |
author_facet | Mehu, Marcelle Narasimhulu, Chandrakala Aluganti Singla, Dinender K. |
author_sort | Mehu, Marcelle |
collection | PubMed |
description | Atherosclerosis is a chronic progressive disease that involves damage to the intima, inflammatory cell recruitment and the accumulation of lipids followed by calcification and plaque rupture. Inflammation is considered a key mediator of many events during the development and progression of the disease. Various types of inflammatory cells are reported to be involved in atherosclerosis. In the present paper, we discuss the involved inflammatory cells, their characteristic and functional significance in the development and progression of atherosclerosis. The detailed understanding of the role of all these cells in disease progression at different stages sheds more light on the subject and provides valuable insights as to where and when therapy should be targeted. |
format | Online Article Text |
id | pubmed-8868126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88681262022-02-25 Inflammatory Cells in Atherosclerosis Mehu, Marcelle Narasimhulu, Chandrakala Aluganti Singla, Dinender K. Antioxidants (Basel) Review Atherosclerosis is a chronic progressive disease that involves damage to the intima, inflammatory cell recruitment and the accumulation of lipids followed by calcification and plaque rupture. Inflammation is considered a key mediator of many events during the development and progression of the disease. Various types of inflammatory cells are reported to be involved in atherosclerosis. In the present paper, we discuss the involved inflammatory cells, their characteristic and functional significance in the development and progression of atherosclerosis. The detailed understanding of the role of all these cells in disease progression at different stages sheds more light on the subject and provides valuable insights as to where and when therapy should be targeted. MDPI 2022-01-26 /pmc/articles/PMC8868126/ /pubmed/35204116 http://dx.doi.org/10.3390/antiox11020233 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Mehu, Marcelle Narasimhulu, Chandrakala Aluganti Singla, Dinender K. Inflammatory Cells in Atherosclerosis |
title | Inflammatory Cells in Atherosclerosis |
title_full | Inflammatory Cells in Atherosclerosis |
title_fullStr | Inflammatory Cells in Atherosclerosis |
title_full_unstemmed | Inflammatory Cells in Atherosclerosis |
title_short | Inflammatory Cells in Atherosclerosis |
title_sort | inflammatory cells in atherosclerosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868126/ https://www.ncbi.nlm.nih.gov/pubmed/35204116 http://dx.doi.org/10.3390/antiox11020233 |
work_keys_str_mv | AT mehumarcelle inflammatorycellsinatherosclerosis AT narasimhuluchandrakalaaluganti inflammatorycellsinatherosclerosis AT singladinenderk inflammatorycellsinatherosclerosis |